At the heart of this moment is a growing unpredictability in how U.S. healthcare policy is being shaped.
William Flemming, PharmD
Advertisement
Articles by William Flemming, PharmD
35 years of manufacturer rebates by any other name.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Next-Gen CDMOs: Keeping Pace With Industry Change
2
Will the Industry Continue to Research Psychedelics?
3
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
4
Novartis Planning Layoffs for 550 Positions at Switzerland Facility
5
